San Diego Sexual Medicine   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: San Diego CA United States (2007)

Organization Overview

First Clinical Trial
2008
NCT00790751
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

San Diego Sexual Medicine | Sue Goldstein

Active Ingredients

Drugs in Phase 4 Trials (3)

flibanserin (addyi) (1 trial)

ospemifene (osphena) (1 trial)

prasterone (intrarosa) (1 trial)

Drugs in Phase 3 Trials (1)

avanafil (stendra) (2 trials)

Drugs in Phase 2 Trials (1)

testosterone (delatestryl) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 4)

Dyspareunia (Phase 4)

Erectile Dysfunction (Phase 3)

Hypogonadism (Phase 2)

Hypokinesia (Phase 4)

Sexual Dysfunctions, Psychological (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 5